Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Empros Pharma AB
AB
Active
Org 5569453862
Nanna Svartz Väg 4, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
5-9 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Empros Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
JA
Jan Arvid Söderhäll
Chief Executive Officer
Chief Executive Officer
2020
RJ
Robert Jan Hasslund
Audit
Audit
2020
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
UC
Ulf Christian Bure Low Holmbäck
Board of Directors
Board of Directors
2022
MZ
Milan Zdravkovic
Board of Directors
Board of Directors
2020
ES
Eugen Steiner
Chairman
Chairman
2022
MR
Mark Royston Quick
Board of Directors
Board of Directors
2022
Former (4)
AB
Anne Bloch Thomsen
Board of Directors
Board of Directors
2022 – 2025
CS
Carl-Johan Spak
Board of Directors
Board of Directors
2020 – 2022
HO
Hans Olof Lennernäs
Board of Directors
Board of Directors
2020 – 2022
LÅ
Lars Åke Martin
Chairman
Chairman
2020 – 2022
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Flerie Invest AB
Company
78%
78%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Empros Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
